Biomarkers and Precision Medicine Community (BPMC)

The Biomarkers and Precision Medicine (BPM) Community is hosting a series of Open Scientific Discussions (OSDs) on Multi-omics in Drug Development.  Please join us for the first OSD in the series hosted on May 30^th, 12 - 1 pm ET:

Part 1: Multi-omics in Precision Medicine

·         What are the factors that influence novel biomarker identification and characterization using multi-omic approaches?

·         What are key considerations when choosing between the various multi-omic technologies?

·         Case studies on the use of multi-omics to support precision medicine will be presented. 

Discussion Leaders:

Matt Blatnik (AbbVie) and Christina Ebert (BMS)

Organized by:  Jurre Kamphorst (Olaris), Iris Qiu (Novartis), Ayuko Ota-Selik and Jianing Zeng (BMS)

We start at 12:00 ET sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.

(Please remain on mute unless asking questions)

When: Thurs, May 30, 2024, 12 pm – 1 pm ET

Where: Please join from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/305789893